Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer

BACKGROUND: Checkpoint inhibitor-related pneumonitis (CIP) is a potentially fatal immune-related adverse event that occurs during treatment with immune checkpoint inhibitors (ICIs). However, the roles played by peripheral blood parameters in CIP development remain unclear. Here, we aimed to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Xinqing, Deng, Haiyi, Yang, Yilin, Wu, Jianhui, Qiu, Guihuan, Li, Suyang, Xie, Xiaohong, Liu, Ming, Xie, Zhanhong, Qin, Yinyin, Song, Yong, Zhou, Chengzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313853/
https://www.ncbi.nlm.nih.gov/pubmed/34327140
http://dx.doi.org/10.3389/fonc.2021.698832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313853/
https://www.ncbi.nlm.nih.gov/pubmed/34327140
http://dx.doi.org/10.3389/fonc.2021.698832

Ejemplares similares